Tempus CEO Eric Lefkofsky Discusses Data Driven Medicine

As the CEO of Tempus, Eric Lefkofsky has a lot to say about data-driven medicine; recently, he sat down with Bloomberg to discuss his thoughts on the subject as well as the moves both himself and Tempus are making within the niche. His first significant thought was about how surprisingly little that technology is used within the healthcare industry compared to many other industries.
Tempus, however, is one of the few companies that’s been driving this and currently provides technological innovations and improvements to over 250 healthcare facilities that they’ve partnered with. But what are the most significant challenges that Eric Lefkofsky sees in the medical field? In his words, it’s the storage of data that patients and practitioners may need to treat a specific illness properly. This is an even greater problem when you factor in major diseases such as cancer. Greater access to personal information within the medical field would all medical practitioners to provide better treatment for their patients.
While that may sound like a difficult problem to overcome, Eric Lefkofsky has led Tempus forward when it comes to overcoming it; as it stands, the company operates the most extensive library of clinical and molecular data in the world which has been actively helping the many medical practitioners that have been using it. The company also developed an operating system to make sure that this medical library was easy for both patients and medical practitioners to use. But what kind of effect will this have on, for example, the costs of medical treatment? While Eric Lefkofsky wasn’t able to comment too specifically on the matter, he did say that Tempus’ innovations were aimed at improving efficiency in the medical field.
In the interview with Bloomberg, he mentioned that by improving efficiency in the filed, the effects would go beyond just the costs associated with medical care. Because of that, medical practitioners will save time and effort when it comes to treating their patients; the result should be the reduction of overall treatment costs. However, that wasn’t Tempus’ main goal, according to Mr. Lefkofsky. They’ve focused on improving the overall quality of healthcare.

Leave a Reply

Your email address will not be published. Required fields are marked *